Yuan Y - Search Results

1

Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects.

Shen H, Yuan Y, Sun J, Gao W, Shu YQ. Shen H, et al. Among authors: yuan y. Biomed Pharmacother. 2010 Feb;64(2):88-92. doi: 10.1016/j.biopha.2009.06.010. Epub 2009 Oct 23. Biomed Pharmacother. 2010. PMID: 20005069

2

[Effect of staurosporine on cell cycle of human gastric cancer cells].

Ha MW, Hou KZ, Liu YP, Yuan Y. Ha MW, et al. Among authors: yuan y. Ai Zheng. 2003 Jul;22(7):691-4. Ai Zheng. 2003. PMID: 12866957 Chinese.

3

[Allicin induced cell cycle arrest in human gastric cancer cell lines].

Ha MW, Yuan Y. Ha MW, et al. Among authors: yuan y. Zhonghua Zhong Liu Za Zhi. 2004 Oct;26(10):585-9. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15634516 Chinese.

4

[Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism].

Hong CY, Xu Q, Yue Z, Zhang Y, Yuan Y. Hong CY, et al. Among authors: yuan y. Ai Zheng. 2009 Dec;28(12):1291-7. doi: 10.5732/cjc.009.10139. Ai Zheng. 2009. PMID: 19958624 Free article. Chinese.

5

XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.

Zhu LB, Xu Q, Hong CY, Yue Z, Zhang Y, Ye HN, Yuan Y. Zhu LB, et al. Among authors: yuan y. Anticancer Drugs. 2010 Aug;21(7):669-73. doi: 10.1097/CAD.0b013e32833ad5aa. Anticancer Drugs. 2010. PMID: 20571354

6

Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.

He C, Duan Z, Li P, Xu Q, Yuan Y. He C, et al. Among authors: yuan y. Anticancer Drugs. 2013 Mar;24(3):300-5. doi: 10.1097/CAD.0b013e32835bd6ce. Anticancer Drugs. 2013. PMID: 23211354 Clinical Trial.

7

Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells.

Wu M, Yuan Y, Pan YY, Zhang Y. Wu M, et al. Among authors: yuan y. Mol Med Rep. 2014 Jun;9(6):2417-22. doi: 10.3892/mmr.2014.2082. Epub 2014 Mar 28. Mol Med Rep. 2014. PMID: 24682085

8

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Wu M, Yuan Y, Pan YY, Zhang Y. Wu M, et al. Among authors: yuan y. Mol Med Rep. 2014 Aug;10(2):931-8. doi: 10.3892/mmr.2014.2243. Epub 2014 May 16. Mol Med Rep. 2014. PMID: 24840891

9

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.

Yao Y, Liu J, Li L, Yuan Y, Nan K, Wu X, Zhang Z, Wu Y, Li X, Zhu J, Meng X, Wei L, Chen J, Jiang Z. Yao Y, et al. Among authors: yuan y. Oncotarget. 2017 Jan 10;8(2):2130-2140. doi: 10.18632/oncotarget.12883. Oncotarget. 2017. PMID: 27791985 Free PMC article.

10

miR-183 inhibits autophagy and apoptosis in gastric cancer cells by targeting ultraviolet radiation resistance-associated gene.

Yuan Y, Zhang Y, Han L, Sun S, Shu Y. Yuan Y, et al. Int J Mol Med. 2018 Dec;42(6):3562-3570. doi: 10.3892/ijmm.2018.3871. Epub 2018 Sep 11. Int J Mol Med. 2018. PMID: 30221685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,256 results

Search Page

Filters